相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ERK-Mediated Phosphorylation of Fibroblast Growth Factor Receptor 1 on Ser777 Inhibits Signaling
Malgorzata Zakrzewska et al.
SCIENCE SIGNALING (2013)
Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells
Zu-Yau Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
Madhu S. Kumar et al.
CELL (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
Mitchell S. Stark et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets
Cheryl Eifert et al.
NATURE REVIEWS CANCER (2012)
Cancer-Associated Loss-of-Function Mutations Implicate DAPK3 as a Tumor-Suppressing Kinase
John Brognard et al.
CANCER RESEARCH (2011)
TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
Shashi Kant et al.
GENES & DEVELOPMENT (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
Illustration of SSMD, z Score, SSMD*, z* Score, and t Statistic for Hit Selection in RNAi High-Throughput Screens
Xiaohua Douglas Zhang
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy
Adi F. Gazdar
CANCER AND METASTASIS REVIEWS (2010)
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
David E. Gerber et al.
CANCER CELL (2010)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
Somatic EGFR Mutation and Gene Copy Gain as Predictive Biomarkers for Response to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Issa J. Dahabreh et al.
CLINICAL CANCER RESEARCH (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
Statistical methods for analysis of high-throughput RNA interference screens
Amanda Birmingham et al.
NATURE METHODS (2009)
p21 activated kinase 5 activates Raf-1 and targets it to mitochondria
Xiaochong Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
Leo H. Wang et al.
NEUROLOGY (2008)
Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
Su-Jiang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
UnPAKing the class differences among p21-activated kinases
Jeyanthy Eswaran et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays
Xiaohua Douglas Zhang
JOURNAL OF BIOMOLECULAR SCREENING (2007)
A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays
Xiaohua Douglas Zhang
GENOMICS (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Oncogenic re-wiring of cellular signaling pathways
T. Pawson et al.
ONCOGENE (2007)
Distinguishing cancer-associated missense mutations from common polymorphisms
Joshua S. Kaminker et al.
CANCER RESEARCH (2007)
siRNA in human cells selectively localizes to target RNA sites
Svitlana Y. Berezhna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Clinical features of 5,628 primary lung cancer patients - Experience at Mayo clinic from 1997 to 2003
P Yang et al.
CHEST (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division
R Kittler et al.
NATURE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mixed-lineage kinase control of JNK and p38 MAPK pathways
KA Gallo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Activated PAK4 regulates cell adhesion and anchorage-independent growth
J Qu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
